Efficacy and Safety of Dabigatran in Patients With Cirrhosis and Portal Vein Thrombosis

Summary

A randomized controlled trial to study the efficacy and safety of Dabigatran in Cirrhotic patients who develop PVT.In this study the patients who meet the inclusion criteria will be randomized to either receive Dabigatran or placebo \[multivitamin tablet\]. Blood samples will be taken \&Imaging will be done accordingly to notice progression or recanalization of PVT.The patients are followed up every 2 months up to 18 month .Then statistical analysis will be done to find whether the Dabigatran is efficacious in cirrhotic patients for recanalization of PVT.

Timeline

Start

2020-06-20

Primary completion

2022-05-31

Completion

2022-05-31

Drugs

Indications